Cargando…

Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma

High-risk neuroblastoma (NB) accounts for 15% of all pediatric cancer deaths. Refractory disease for high-risk NB patients is attributed to chemotherapy resistance and immunotherapy failure. The poor prognosis for high-risk NB patients demonstrates an unmet medical need for the development of new, m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mills, Catherine M., Benton, Thomas Z., Piña, Ivett, Francis, Megan J., Reyes, Leticia, Dolloff, Nathan G., Peterson, Yuri K., Woster, Patrick M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945084/ https://www.ncbi.nlm.nih.gov/pubmed/36845935 http://dx.doi.org/10.1039/d2sc05749b

Ejemplares similares

Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation
por: Benton, Thomas Z., et al.
Publicado: (2021)

Small molecules targeting the NADH-binding pocket of VDAC modulate mitochondrial metabolism in hepatocarcinoma cells
por: Heslop, Kareem A., et al.
Publicado: (2022)

Identification and Characterization of Novel Small-Molecule SMOX Inhibitors
por: Furbish, Amelia B., et al.
Publicado: (2022)

CD38: An Immunomodulatory Molecule in Inflammation and Autoimmunity
por: Piedra-Quintero, Zayda L., et al.
Publicado: (2020)

Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+ neuroblastoma cells undergo apoptosis following interaction with CD40L
por: Airoldi, I, et al.
Publicado: (2003)

PDI inhibitor LTI6426 enhances panobinostat efficacy in preclinical models of multiple myeloma
por: Robinson, Reeder M., et al.
Publicado: (2022)

High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells
por: Clara, Joseph Andrew, et al.
Publicado: (2022)

Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
por: Horenstein, Alberto L., et al.
Publicado: (2018)

434 In silico ADMET optimization and preliminary biologic activity of novel spermine oxidase inhibitors as neuroprotective agents
por: Furbish, Amelia B, et al.
Publicado: (2022)

CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide
por: Gurney, Mark, et al.
Publicado: (2020)

Natural Killer T Cells Infiltrate Neuroblastomas Expressing the Chemokine CCL2
por: Metelitsa, Leonid S., et al.
Publicado: (2004)

Natural Killer Cell Deficiency in Neuroblastoma Amplified Sequence Gene Mutation
por: Albar, Rawia F, et al.
Publicado: (2021)

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma
por: Poels, Renée, et al.
Publicado: (2021)

ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56(dim)CD16(+) and CD56(bright)CD16(dim/−) natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients
por: Huth, Teilah Kathryn, et al.
Publicado: (2016)

The biguanide polyamine analog verlindamycin promotes differentiation in neuroblastoma via induction of antizyme
por: Urban-Wójciuk, Zuzanna, et al.
Publicado: (2021)

Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells
Publicado: (1991)

Natural killer cells facilitate PRAME-specific T-cell reactivity against neuroblastoma
por: Spel, Lotte, et al.
Publicado: (2015)

Rough Net Approach for Community Detection Analysis in Complex Networks
por: Fuentes, Ivett, et al.
Publicado: (2020)

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.
por: Foreman, N. K., et al.
Publicado: (1993)

Chromosome instability in neuroblastoma
por: Fusco, Pina, et al.
Publicado: (2018)

Prozone effect of serum IgE levels in a case of plasma cell leukemia
por: Talamo, Giampaolo, et al.
Publicado: (2010)

2028 Discovery and evaluation of FOXP3 dimerization inhibitors
por: Thompson, Ravyn, et al.
Publicado: (2018)

Transcriptome profiling reveals the role of ZBTB38 knock-down in human neuroblastoma
por: Chen, Jie, et al.
Publicado: (2019)

Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis
por: Tabellini, Giovanna, et al.
Publicado: (2014)

CD38 in Neurodegeneration and Neuroinflammation
por: Guerreiro, Serge, et al.
Publicado: (2020)

Stimulation of Natural Killer T Cells by Glycolipids
por: Anderson, Brian L., et al.
Publicado: (2013)

A molecular signature of dormancy in CD34(+)CD38(-) acute myeloid leukaemia cells
por: Al-Asadi, Mazin Gh., et al.
Publicado: (2017)

Neuroblastoma occurring in a 38-year old Nigerian man: a rare finding
por: Nzegwu, Martin A, et al.
Publicado: (2009)

Neonatal Sacrococcygeal Neuroblastoma Mimicking a Teratoma
por: Gely, Leticia, et al.
Publicado: (2017)

Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometry
por: Balinas, Cassandra, et al.
Publicado: (2019)

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment
por: Motais, Benjamin, et al.
Publicado: (2021)

Relationship of the Content of Systemic and Endobronchial Soluble Molecules of CD25, CD38, CD8, and HLA-I-CD8 and Lung Function Parameters in COPD Patients
por: Kubysheva, Nailya, et al.
Publicado: (2017)

Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
por: Bottino, Cristina, et al.
Publicado: (2014)

Antibody‐dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells
por: Mise, Naoko, et al.
Publicado: (2016)

Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells
por: Vitale, Chiara, et al.
Publicado: (2023)

Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells
por: Rohn, Hana, et al.
Publicado: (2022)

CD146 is a potential immunotarget for neuroblastoma
por: Obu, Satoshi, et al.
Publicado: (2021)

Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27(−)CD38(+)IFN-γ(+)CD4(+) T cells for discrimination of active tuberculosis
por: Fang, Yong, et al.
Publicado: (2022)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
por: Plesner, Torben, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_igkdkiv8blfjj5qod7m3q4sbnu